Stock screenerAll disclosures →
EDGAR →
IMDX
Conviction 11HealthcareScan · Mon, Aug 10, 2026IMDX$4.78-1.14%
ResistanceSupportVol 14Insider buyVol MA14 119.01K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price4.78
Change-1.14%
Gap+0.21%
Rel volume0.39×
Avg volume136.07K
Avg $ vol648.51K
SMA 204.79
SMA 505.24
SMA 2005.48
Price vs 50-8.81%
Price vs 200-12.81%
MA stackbearish
50/200 crossdeath · 8d
Supertrenddown · 5.58
RSI (14)46
MACD hist0.04
MACD crossbull · 5d
Stoch %K / %D44 / 47
ADX (14)17
+DI / −DI17 / 21
RSI divergence—
MACD divergenceBullish
ATR %+7.72%
ADR %6.50%
52w high8.48
52w low2.40
From 52w high-43.69%
Above 52w low+98.96%
New 52w highNo
SqueezeOn · 7d
Bollinger width15.87%
%B0.48
Donchian pos47.34%
Donchian high5.32
Donchian low4.29
AVWAP (52w high)4.91
vs AVWAP high-2.69%
AVWAP (52w low)4.90
vs AVWAP low-2.59%
OBV trendDown
Chaikin MF (20)-0.03
Today vs 20d0.39×
Avg vol (14d)119.01K
Avg vol (20d)136.07K
Avg $ vol (20d)648.51K
Market cap—
RS 3m (vs SPY)-8.32%
RS 6m (vs SPY)-41.92%
RS line new highNo
Trend template2/8
Technical rank22.6
1 week-5.07%
1 month-6.00%
3 months-4.69%
6 months-34.77%
1 year+81.90%
YTD-33.31%
P/E-3.10
P/B-14.56
P/S38.38
P/FCF-6.13
EPS-1.65
Div yield—
ROE469.76%
ROA-124.23%
Debt/Eq-0.17
Current2.54
EV/EBITDA-2.64
Gross margin56.67%
Net margin—
Rev growth115.58%
EPS growth17.21%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value129.31M
Revenue32K
Net income-4.29M
Gross profit15K
Free cash flow-25.37M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out32.29M
Employees58
ListedWed, Dec 30, 2015
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction11 / 100
Pattern quality—
Tech rank22.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.69
Support4.32
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in IMDX
No recent disclosed trades by Congress in IMDX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IMDX · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Arno Andrew Director · Common Stock, no par value · 2026-07-01 | Tax | 12.1K | $69K | 2026-07-01 | 2026-07-06 |
BROADWOOD CAPITAL INC 10% owner · Common Stock, no par value · 2026-04-27 | Buy | 250.92K | $913K | 2026-04-27 | 2026-04-27 |
Bradsher Neal C 10% owner · Common Stock, no par value · 2026-04-27 | Buy | 0 | $0 | 2026-04-27 | 2026-04-27 |
BROADWOOD PARTNERS, L.P. 10% owner · Common Stock, no par value · 2026-04-27 | Buy | 0 | $0 | 2026-04-27 | 2026-04-27 |
BROADWOOD PARTNERS, L.P. 10% owner · Common Stock, no par value · 2026-04-27 | Buy | 250.92K | $913K | 2026-04-27 | 2026-04-27 |
BROADWOOD CAPITAL INC 10% owner · Common Stock, no par value · 2026-04-27 | Buy | 0 | $0 | 2026-04-27 | 2026-04-27 |
Bradsher Neal C 10% owner · Common Stock, no par value · 2026-04-27 | Buy | 250.92K | $913K | 2026-04-27 | 2026-04-27 |
BROADWOOD CAPITAL INC 10% owner · Common Stock, no par value · 2026-04-24 | Buy | 0 | $0 | 2026-04-24 | 2026-04-27 |
BROADWOOD PARTNERS, L.P. 10% owner · Common Stock, no par value · 2026-04-24 | Buy | 0 | $0 | 2026-04-24 | 2026-04-27 |
BROADWOOD CAPITAL INC 10% owner · Common Stock, no par value · 2026-04-24 | Buy | 38.88K | $137K | 2026-04-24 | 2026-04-27 |
SEC filings
EDGAR filings in IMDX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.